Patient adherence and data accuracy are non-negotiable in vaccine clinical studies. Inadequate reporting can jeopardize regulatory submissions, raise expenses, and postpone the conclusion of studies.
However, many vaccine clinical trials are plagued by low adherence rates and ineffective data collection, which can result in insufficient safety monitoring and possible protocol violations.
TrialPal, a program created especially for vaccine clinical trials, can help. It offers the fastest tailored ePRO setup and +98% adherence rates including elderly populations.
Why Vaccine Clinical Trials Need a Tailored ePRO Solution?
Integra IT’s COO, Silvana Marangon, has worked with leading clinical research companies such as IQVIA, ICON, and Syneos for over ten years. She has personal experience with the challenges that research teams have when attempting to use conventional ePRO systems in vaccine studies.
“Vaccine clinical trials are unique. However, all too frequently, research teams are compelled to employ generic ePRO solutions that aren’t made to meet the demands of these studies in terms of speed, complexity, volume of participants, and compliance. Delays, expensive setup fees, and needless complications were the most common outcomes when using generic ePROs.” – Silvana Marangon.
TrialPal removes these obstacles. It is a quick, effective, and fully compliant ePRO/eCOA solution created especially for vaccine clinical trials. It helps research teams go from setup to IRB-ready screens in as little as two days, keep track of every report received in real-time, intensities, symptoms reported, AEs addressed, etc.
How TrialPal Changes Vaccine Clinical Trials?
In Just Two Days, IRB-Ready
Configuring traditional ePRO solutions can take weeks or months. TrialPal reduces this to 48 hours, enabling studies to begin without needless delays and offering IRB screens ready for compliance checks. It uses our already built-in symptoms library, definitions, rules, easy cohort configuration, languages, time zones, etc.
Intelligent Reporting Functionalities for Optimal Compliance
Subjects can easily record symptoms, adverse events (AEs), and serious adverse events (SAEs) in real time with diaries & Symptom Tracking.
- Linked Forms: Gather demographic information, lifestyle variables, and group evaluations all in one app.
- Multiple Entry Options: For improved data accuracy, participants can submit reports several times a day with a defined time window.
Perceptive Warnings & Reminders
- Scheduled Reminders: Set up reminders automatically to guarantee prompt subject reporting. Setup frequency for the automatic reminders to be displayed in the subject’s smartphone
- Real-Time Alerts: These alerts enable prompt action by highlighting safety issues immediately to all study stakeholders, from PI to the CRO or Sponsor Project lead.
- Tailored Notifications: Adjust reporting windows to suit the requirements of each study.
An Engaging User Experience
- Complete Offline Functionality: This is crucial to gathering accurate data in places with poor internet connectivity or among marginalized communities. The app works completely without the internet and stores reports on the device until it senses an internet signal back to send them to the central server.
- Multi-Platform Access: The system features an easy-to-use, intuitive design app and is accessible on mobile, PWA and web platforms. One solution, different channels. Already approved by iOS and Google Play, no need to add time to the project schedule hoping to get a new approval for your study.
- Multilingual Support: Use language-specific, and tech adoption tactics to boost particpants involvement.
Smooth Integration for More Intelligent Trials
TrialPal is more than just an ePRO tool; it is a comprehensive eCOA solution tailored to any study protocol. It guarantees participant involvement, compliance, and smooth data integration with popular EDC systems through its robust API.
Do you want to watch TrialPal in use?
Get a free demo now to see how it helps streamline your vaccine studies by lowering site burden, enhancing adherence, and shortening research durations.
